12.2 C
New York
Monday, June 5, 2023

The Question Is Whether To Buy Or Not To Buy CareDx Inc (NASDAQ: CDNA)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for CareDx Inc (CDNA) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.17, or -1.97%, to $8.44. The CareDx Inc has recorded 50,685 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

CareDx Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Diagnostics & Research industry. At the end of the last regular session, the stock closed at $8.61 and fluctuated between $8.75 as its day high and $8.18 as its day low. The current market capitalization of CareDx Inc is $444.45M. A total of 0.74 million shares were traded on the day, compared to an average of 1.40M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, CDNA has seen 2 BUY and 6 SELL insider trades, representing the acquisition of 3,647 and the disposition of 28,912 shares. Over the last 12 months, there were 46 BUYs and 31 SELLs from insiders. Insiders purchased 890,408 shares during that period but sold 106,500.

In the most recent transaction, Seeto Reginald sold 2,819 shares of CDNA for 8.12 per share on May 02. After the transaction, the insider now owns 534,996 company shares. In a previous transaction on Apr 03, Seeto Reginald sold 2,818 shares at 8.95 per share. CDNA shares that insider owns now total 537,815.

Among the insiders who sold shares, Seeto Reginald disposed of 2,819 shares on Mar 02 at a per-share price of $15.88. This resulted in the insider holding 540,633 shares of CDNA after the transaction. In another insider transaction, Seeto Reginald sold 8,488 shares at $15.48 per share on Feb 10. Company shares held by the insider now total 543,452.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for CDNA in the last 3 months, the mean price target is $14.80 with high estimates of $24.00 and low estimates of $9.00. In terms of 52-week highs and lows, CDNA has a high of $34.30 and a low of $7.63.

As of this writing, CDNA has an earnings estimate of -$0.11 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.05 per share and a lower estimate of -$0.21. The company reported an EPS of -$0.06 in the last quarter, which was 57.10% higher than expectations of -$0.14.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CDNA’s latest balance sheet shows that the firm has $348.49M in Cash & Short Term Investments as of fiscal 2021. There were $17.39M in debt and $77.30M in liabilities at the time. Its Book Value Per Share was $8.05, while its Total Shareholder’s Equity was $465.88M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDNA is Buy with a score of 3.86.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles